216 related articles for article (PubMed ID: 28942133)
41. Automated screening with confirmation of mechanism-based inactivation of CYP3A4, CYP2C9, CYP2C19, CYP2D6, and CYP1A2 in pooled human liver microsomes.
Lim HK; Duczak N; Brougham L; Elliot M; Patel K; Chan K
Drug Metab Dispos; 2005 Aug; 33(8):1211-9. PubMed ID: 15860655
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of in vitro cytochrome P450 induction and inhibition activity of deoxyelephantopin, a sesquiterpene lactone from Elephantopus scaber L.
Koe XF; Lim EL; Seah TC; Amanah A; Wahab HA; Adenan MI; Sulaiman SF; Tan ML
Food Chem Toxicol; 2013 Oct; 60():98-108. PubMed ID: 23876819
[TBL] [Abstract][Full Text] [Related]
43. In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug-drug interactions.
Wójcikowski J; Danek PJ; Basińska-Ziobroń A; Pukło R; Daniel WA
Pharmacol Rep; 2020 Jun; 72(3):612-621. PubMed ID: 32219694
[TBL] [Abstract][Full Text] [Related]
44. Inhibitory and inductive effects of Phikud Navakot extract on human cytochrome P450.
Chiangsom A; Lawanprasert S; Oda S; Kulthong K; Luechapudiporn R; Yokoi T; Maniratanachote R
Drug Metab Pharmacokinet; 2016 Jun; 31(3):210-7. PubMed ID: 27212065
[TBL] [Abstract][Full Text] [Related]
45. Exploring the possible metabolism mediated interaction of Glycyrrhiza glabra extract with CYP3A4 and CYP2D6.
Pandit S; Ponnusankar S; Bandyopadhyay A; Ota S; Mukherjee PK
Phytother Res; 2011 Oct; 25(10):1429-34. PubMed ID: 21351298
[TBL] [Abstract][Full Text] [Related]
46. Metabolism-mediated interaction potential of standardized extract of
Bahadur S; Mukherjee PK; Milan Ahmmed SK; Kar A; Harwansh RK; Pandit S
Indian J Pharmacol; 2016; 48(5):576-581. PubMed ID: 27721546
[TBL] [Abstract][Full Text] [Related]
47. Prediction of maternal pharmacokinetics using physiologically based pharmacokinetic models: assessing the impact of the longitudinal changes in the activity of CYP1A2, CYP2D6 and CYP3A4 enzymes during pregnancy.
Abduljalil K; Pansari A; Jamei M
J Pharmacokinet Pharmacodyn; 2020 Aug; 47(4):361-383. PubMed ID: 32840724
[TBL] [Abstract][Full Text] [Related]
48.
Zhang N; Liu J; Chen Z; Dou W
Pharm Biol; 2019 Dec; 57(1):571-576. PubMed ID: 31456483
[No Abstract] [Full Text] [Related]
49. In vivo pharmacokinetic interaction by ethanolic extract of Gymnema sylvestre with CYP2C9 (Tolbutamide), CYP3A4 (Amlodipine) and CYP1A2 (Phenacetin) in rats.
Vaghela M; Sahu N; Kharkar P; Pandita N
Chem Biol Interact; 2017 Dec; 278():141-151. PubMed ID: 29042257
[TBL] [Abstract][Full Text] [Related]
50. The in vitro inhibition of human CYP1A2, CYP2D6 and CYP3A4 by tetrahydropalmatine, neferine and berberine.
Zhao Y; Hellum BH; Liang A; Nilsen OG
Phytother Res; 2012 Feb; 26(2):277-83. PubMed ID: 21678521
[TBL] [Abstract][Full Text] [Related]
51. Effects of Panax notoginseng saponins on the activities of CYP1A2, CYP2C9, CYP2D6 and CYP3A4 in rats in vivo.
Liu R; Qin M; Hang P; Liu Y; Zhang Z; Liu G
Phytother Res; 2012 Aug; 26(8):1113-8. PubMed ID: 22162298
[TBL] [Abstract][Full Text] [Related]
52. The potential of Epimedium koreanum Nakai for herb-drug interaction.
Zhong Q; Shi Z; Zhang L; Zhong R; Xia Z; Wang J; Wu H; Jiang Y; Sun E; Wei Y; Feng L; Zhang Z; Liu D; Song J; Jia X
J Pharm Pharmacol; 2017 Oct; 69(10):1398-1408. PubMed ID: 28653752
[TBL] [Abstract][Full Text] [Related]
53. In vitro inhibitory effects of pristimerin on human liver cytochrome P450 enzymes.
Hao X; Yuan J; Xu Y; Wang Z; Hou J; Hu T
Xenobiotica; 2018 Dec; 48(12):1185-1191. PubMed ID: 28385095
[TBL] [Abstract][Full Text] [Related]
54.
Zhao H; Xue S; Meng Q; Zhou C
Xenobiotica; 2021 Sep; 51(9):977-982. PubMed ID: 34176447
[TBL] [Abstract][Full Text] [Related]
55. Inhibitory Activities of Thai Medicinal Plants with Promising Activities Against Malaria and Cholangiocarcinoma on Human Cytochrome P450.
Sumsakul W; Mahavorasirikul W; Na-Bangchang K
Phytother Res; 2015 Dec; 29(12):1926-33. PubMed ID: 26490449
[TBL] [Abstract][Full Text] [Related]
56. Investigation of CYP2B6, 3A4 and β-esterase interactions of Withania somnifera (L.) dunal in human liver microsomes and HepG2 cells.
Kumar S; Bouic PJ; Rosenkranz B
J Ethnopharmacol; 2021 Apr; 270():113766. PubMed ID: 33395575
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of the impact of cantharidin on rat CYP enzymes by using a cocktail of probe drugs.
Zhou CJ; Qiao LM; Zhao LH; Li ZY
Fitoterapia; 2015 Dec; 107():49-53. PubMed ID: 26498206
[TBL] [Abstract][Full Text] [Related]
58. Effect of Curcuma longa on CYP2D6- and CYP3A4-mediated metabolism of dextromethorphan in human liver microsomes and healthy human subjects.
Al-Jenoobi FI; Al-Thukair AA; Alam MA; Abbas FA; Al-Mohizea AM; Alkharfy KM; Al-Suwayeh SA
Eur J Drug Metab Pharmacokinet; 2015 Mar; 40(1):61-6. PubMed ID: 24510399
[TBL] [Abstract][Full Text] [Related]
59. In vitro effects of active constituents and extracts of Orthosiphon stamineus on the activities of three major human cDNA-expressed cytochrome P450 enzymes.
Pan Y; Abd-Rashid BA; Ismail Z; Ismail R; Mak JW; Pook PC; Er HM; Ong CE
Chem Biol Interact; 2011 Mar; 190(1):1-8. PubMed ID: 21276781
[TBL] [Abstract][Full Text] [Related]
60. Hyptis suaveolens (L.) Poit protects colon from TNBS-induced inflammation via immunomodulatory, antioxidant and anti-proliferative mechanisms.
Machado FDF; Formiga RO; Lima GRM; de Jesus NZT; Alves Júnior EB; Marinho AF; Tavares JF; Santos FA; Viana AFSC; Araújo AA; de Araújo Júnior RF; Pellizzon CH; Batista LM
J Ethnopharmacol; 2021 Jan; 265():113153. PubMed ID: 32702379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]